AlphaCentric Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.76M | Buy |
|
|||||
|
2024
Q1 | $1.62M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $413K | Hold |
|
|||||
|
2023
Q2 | $509K | Hold |
|
|||||
|
2023
Q1 | $540K | Hold |
|
|||||
|
2022
Q4 | $669K | Sell |
|
|||||
|
2022
Q3 | $478K | Buy |
|
|||||
|
2021
Q4 | $657K | Hold |
|
|||||
|
2021
Q3 | $918K | Sell |
|
|||||
|
2021
Q2 | $836K | Hold |
|
|||||
|
2021
Q1 | $515K | Buy |
|
|||||
|
2020
Q4 | $61K | Hold |
|
|||||
|
2020
Q3 | $52K | Buy |
|